Aquestive TherapeuticsvsMerck & Company

AQST and MRK stock compared: price, dividend, valuation and results, from SEC filings.

AQST

Aquestive Therapeutics, Inc.

$3.71

Value $452M

-1.98%
AQST's page

MRK

Merck & Company, Inc.

$132.74

Value $328B

-3.66%
MRK's page

Aquestive Therapeutics (AQST) has a market value of $452M and Merck & Company (MRK) $328B. Over the last year, with dividends, AQST moved -37.4% and MRK +41.7%. Dividend yield: AQST none, MRK 2.56%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AQST$452M

    MRK$328B

    MRK is 726 times AQST

  • Revenue, 12 months

    AQST$49M

    MRK$67.4B

    MRK is 1,380 times AQST

  • Net income, 12 months

    AQST-$79M

    MRK$2.5B

  • Operating margin

    AQST-114.1%

    MRK–

  • ROIC

    AQST-737.8%

    MRK3.9%

    741.6 points apart

  • P/E

    AQST–

    MRK133.8

  • Dividend yield

    AQST0.0%

    MRK2.6%

    2.6 points apart

  • 5-year return

    AQST-33.3%

    MRK+86.2%

    119.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AQST-33.3%

MRK+86.2%

010020020222023202420252026
Returns by period
PeriodAQSTWith dividendsMRKWith dividends
1 year since November 18, 2025-37.4%Price -37.4%+41.7%Price +37.7%
3 years since November 17, 2023+113.9%+28.8% a yearPrice +113.9%+43.0%+12.7% a yearPrice +30.5%
5 years since November 18, 2021-33.3%-7.8% a yearPrice -33.3%+86.2%+13.2% a yearPrice +59.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AQSTAquestive TherapeuticsMRKMerck & Company

Valuation

AQSTMRK
Valuation
Price$3.71$132.74
Market value$452M$328B
Enterprise value (EV)–$372B
P/E–133.8
P/E, 5-year median–14.8
P/B–7.3
EV/EBIT–78.2
Free cash flow yield–4.5%

Results and growth

AQSTMRK
Results and growth
Revenue, 12 months$49M$67.4B
Net income, 12 months-$79M$2.5B
Free cash flow, 12 months-$41M$14.7B
Earnings per share, 12 months-$0.65$0.98
Revenue growth, year on year-22.6%1.3%
Revenue growth a year, past-0.6%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

AQSTMRK
Margins and returns on capital
Gross margin65.3%71.8%
Operating margin-114.1%–
Net margin-162.3%3.6%
ROIC-737.8%3.9%
ROE–5.2%

Balance sheet

AQSTMRK
Balance sheet
Cash$90M$9.7B
Total debt–$53.8B
Net debt / EBITDA–5.7
Interest cover-5.4×2.4×

Dividends and buybacks

AQSTMRK
Dividends and buybacks
Dividend yield–2.6%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.6%
Shareholder yield–4.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AQST or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Aquestive Therapeutics or Merck & Company?

By market value, Merck & Company ($328B) is about 725.8 times Aquestive Therapeutics ($452M), at today's prices.

How did AQST and MRK stock do over the last 5 years?

Since November 18, 2021, AQST's price moved -33.3% and MRK's +59.8%. With dividends: AQST -33.3% (-7.8% a year), MRK +86.2% (+13.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, AQST or MRK?

The dividend yield at today's price is none for Aquestive Therapeutics and 2.56% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

Which has the higher profit margins, Aquestive Therapeutics or Merck & Company?

Over the last twelve months, the net margin was -162.3% for Aquestive Therapeutics and 3.6% for Merck & Company, and the operating margin -114.1% and –. Revenue was $49M and $67.4B.

Which is the better investment, Aquestive Therapeutics or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.